Table 1 The MICs of glutaraldehyde in clinical isolates during 1991–2000.
From: Synergistic effect of imp/ostA and msbA in hydrophobic drug resistance of Helicobacter pylori
Disease | Number of isolates | The MICs of glutaraldehyde in isolates (numbers) |
|---|---|---|
Gastritis | 15 | 7 μg/ml (n = 2), 6 μg/ml (n = 1) 5 μg/ml (n = 3), 4 μg/ml (n = 4) 3 μg/ml (n = 5) |
Duodenal ulcer | 16 | 10 μg/ml (n = 1), 7 μg/ml (n = 1) 6 μg/ml (n = 2), 5 μg/ml (n = 3) 4 μg/ml (n = 5), 2 μg/ml (n = 2) 1.5 μg/ml (n = 1), 1 μg/ml (n = 1) |
Gastric ulcer | 9 | 10 μg/ml (n = 1), 7 μg/ml (n = 1) 6 μg/ml (n = 3), 5 μg/ml (n = 1) 3 μg/ml (n = 1), 1.5 μg/ml (n = 1) 1 μg/ml (n = 1) |
MALToma | 3 | 7 μg/ml (n = 1), 5 μg/ml (n = 2) |
Gastric cancer | 6 | 6 μg/ml (n = 3), 5 μg/ml (n = 1) 3 μg/ml (n = 2) |